ArticleSpringerPlus2013

Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.

Anja Bumb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.